[KongchangAI]
Unverified50% confidenceFactExact time

The European LeukemiaNet (ELN) 2022 guidelines recommend MRD assessment at key treatment milestones.

1
Sources
50%
Confidence
Long-term
Relevance
9/6/2026
First Seen

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/864687
API
curl https://kongchang.com/api/v1/knowledge/claims/864687
MCP
get_claim(id=864687)